CD24-CD44+ is a marker for breast cancer CSC [22]; we found that TIM overexpression expanded the CD24-CD44+ subpopulation and its knockdown reduced the CD24-CD44+subpopulation (Fig. 2c). This evidence concerns the gene CD44 and breast carcinoma.